Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weichselbaum

Showing results (681-690 of 727) with videos related to

Pageof 73
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancerEverett E Vokes, Kerstin Stenson, Fred R Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremitiesArno J Mundt, Srinivasan Vijayakumar, John Nemunaitis, et al.
Plos One|June 9, 2009
STAT1 pathway mediates amplification of metastatic potential and resistance to therapyNikolai N Khodarev, Paul Roach, Sean P Pitroda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2024
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal SitesYuzhu Hou, Kaiting Yang, Liangliang Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2008
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerRalph R Weichselbaum, Hemant Ishwaran, Taewon Yoon, et al.
Cancer Research|April 4, 2019
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in GlioblastomaDavid J Voce, Giovanna M Bernal, Longtao Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2021
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC StudyChristine M Bestvina, Kelli B Pointer, Theodore Karrison, et al.
Cancer|October 25, 2011
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic diseaseJoseph K Salama, Michael D Hasselle, Steven J Chmura, et al.
Cancer Research|May 16, 2000
Anti-angiogenic cues from vascular basement membrane collagenP C Colorado, A Torre, G Kamphaus, et al.
Cell Reports|March 9, 2017
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon ResponseAbdul S Qadir, Paolo Ceppi, Sonia Brockway, et al.
Pageof 73

Showing results (681-690 of 727) with videos related to

Sort By:
Pageof 73
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancerEverett E Vokes, Kerstin Stenson, Fred R Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremitiesArno J Mundt, Srinivasan Vijayakumar, John Nemunaitis, et al.
Plos One|June 9, 2009
STAT1 pathway mediates amplification of metastatic potential and resistance to therapyNikolai N Khodarev, Paul Roach, Sean P Pitroda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2024
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal SitesYuzhu Hou, Kaiting Yang, Liangliang Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2008
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerRalph R Weichselbaum, Hemant Ishwaran, Taewon Yoon, et al.
Cancer Research|April 4, 2019
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in GlioblastomaDavid J Voce, Giovanna M Bernal, Longtao Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2021
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC StudyChristine M Bestvina, Kelli B Pointer, Theodore Karrison, et al.
Cancer|October 25, 2011
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic diseaseJoseph K Salama, Michael D Hasselle, Steven J Chmura, et al.
Cancer Research|May 16, 2000
Anti-angiogenic cues from vascular basement membrane collagenP C Colorado, A Torre, G Kamphaus, et al.
Cell Reports|March 9, 2017
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon ResponseAbdul S Qadir, Paolo Ceppi, Sonia Brockway, et al.
Pageof 73